Research

Scientists at UCSF Study Impact of 68Ga-PSMA-11 PET on Post Radical Prostatectomy (RP) Salvage Radiotherapy

Recently, scientists from the UC San Francisco Departments of Radiology and Biomedical Imaging, Urology and Radiation Oncology came together to study the impact of 68Ga-PSMA-11 PET on post radical prostatectomy (RP) salvage radiotherapy.

Gene Therapy Trial for Parkinson's Disease Uses Intra-Operative MRI-Guided Monitoring

Scientists at UC San Francisco have pioneered the use of gene therapy to address Parkinson's disease. UCSF Radiology's Dr. Alastair Martin was a co-author in this research

Rahul Desikan, MD, PhD Investigates the Science and Experience of ALS

Even as Rahul Desikan, MD, PhD battles amyotrophic lateral sclerosis (ALS) himself, he continues the rigorous lines of questioning that led him to become a leading investigator focused on neurogenerative diseases. 

Drs. Rahul Desikan and Leo Sugrue Discuss Genomic Medicine and Neurogenerative Diseases

Rahul Desikan, MD, PhD, and Leo Sugrue, MD, PhD recently discussed polygenic scores and why they are important in Scientific American.

UCSF Researchers Publish Initial Results on FES-dbPET Imaging of ER+ Breast Cancers

Researchers with the UC San Francisco Department of Radiology and Biomedical Imaging set out to evaluate FES-dbPET technology for enabling a more precise characterization of ER+ breast cancers.

Researchers Assess the Accuracy of 68Ga-PSMA-11 PET in Localizing Prostate Cancer

Scientists at UCSF and UCLA designed a single-arm prospective trial on 635 patients with biochemically recurrent prostate cancer to assess the accuracy of 68Ga-PSMA-11 PET.

First-Of-Its-Kind Study Demonstrates Clinical Impact of Amyloid PET Imaging

Amyloid PET imaging to predict Alzheimer's disease dramatically alters physicians' care decisions for patients with mild cognitive impairment/dementia, according to the nationwide IDEAS study.

Hyperpolarized 13C MRI as an Emerging Molecular Imaging Technique

Hyperpolarized (HP) carbon 13 (13C) MRI is an emerging molecular imaging technique that is actively undergoing clinical translation at multiple institutions. At UCSF Radiology, we are engaged in work to develop this new technology.

UCSF, UC Berkeley and 3D Printer Carbon, Inc. Team Up to Create a Drug Sponge to Absorb Excess Chemotherapy Medication

Steven Hetts, MD, and a team from his lab, UC Berkeley and Carbon Inc. (3D printer) developed a drug sponge, that removes excess chemotherapy from the blood while treating tumors, preventing toxicity.

Pages